Nutrition Research and Practice

  • 제7권6호
  • /
  • Pages.481-487
  • /
  • 2013
  • /
  • 1976-1457(pISSN)
  • /
  • 2005-6168(eISSN)
한국영양학회 (The Korean Nutrition Society)
권호 표지
DOI QR코드

DOI QR Code

Effects of d-${\alpha}$-tocopherol supplements on lipid metabolism in a high-fat diet-fed animal model

  • Kim, Do Yeon (Department of Medical Nutrition, Graduate School of East-West Medical Science, Kyung Hee University) ;
  • Kim, Jinkyung (Department of Medical Nutrition, Graduate School of East-West Medical Science, Kyung Hee University) ;
  • Ham, Hye Jin (Department of Medical Nutrition, Graduate School of East-West Medical Science, Kyung Hee University) ;
  • Choue, Ryowon (Department of Medical Nutrition, Graduate School of East-West Medical Science, Kyung Hee University)
  • 투고 : 2012.11.09
  • 심사 : 2013.08.12
  • 발행 : 2013.12.01
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

High-fat diet up-regulates either insulin resistance or triglycerides, which is assumed to be related to the expression of peroxisome proliferator-activated receptor (PPAR)-${\alpha}$ and PPAR-${\gamma}$. The beneficial effects of vitamin E on insulin resistance are well known; however, it is not clear if vitamin E with a high-fat diet alters the expression of PPAR-${\alpha}$ and PPAR-${\gamma}$. We investigated the effects of d-${\alpha}$-tocopherol supplementation on insulin sensitivity, blood lipid profiles, lipid peroxidation, and the expression of PPAR-${\alpha}$ and PPAR-${\gamma}$ in a high-fat (HF) diet-fed male C57BL/6J model of insulin resistance. The animals were given a regular diet (CON; 10% fat), a HF diet containing 45% fat, or a HF diet plus d-${\alpha}$-tocopherol (HF-E) for a period of 20 weeks. The results showed that the HF diet induced insulin resistance and altered the lipid profile, specifically the triglyceride (TG) and total cholesterol (TC) levels (P < 0.05). In this animal model, supplementation with d-${\alpha}$-tocopherol improved insulin resistance as well as the serum levels of TG and very-low-density lipoprotein-cholesterol (VLDL-C) (P < 0.05). Moreover, the treatment decreased the levels of malondialdehyde (MDA) in the serum and liver while increasing hepatic PPAR-${\alpha}$ expression and decreasing PPAR-${\gamma}$ expression. In conclusion, the oral administration of d-${\alpha}$-tocopherol with a high-fat diet had positive effects on insulin resistance, lipid profiles, and oxidative stress through the expression of PPAR-${\alpha}$ and PPAR-${\gamma}$ in a high-fat diet-fed male mice.

키워드

참고문헌

  1. Lovejoy JC, Champagne CM, Smith SR, DeLany JP, Bray GA, Lefevre M, Denkins YM, Rood JC. Relationship of dietary fat and serum cholesterol ester and phospholipid fatty acids to markers of insulin resistance in men and women with a range of glucose tolerance. Metabolism 2001;50:86-92. https://doi.org/10.1053/meta.2001.19440
  2. Mayer-Davis EJ, Monaco JH, Hoen HM, Carmichael S, Vitolins MZ, Rewers MJ, Haffner SM, Ayad MF, Bergman RN, Karter AJ. Dietary fat and insulin sensitivity in a triethnic population: the role of obesity. The Insulin Resistance Atherosclerosis Study (IRAS). Am J Clin Nutr 1997;65:79-87. https://doi.org/10.1093/ajcn/65.1.79
  3. Lovejoy JC, Windhauser MM, Rood JC, de la Bretonne JA. Effect of a controlled high-fat versus low-fat diet on insulin sensitivity and leptin levels in African-American and Caucasian women. Metabolism 1998;47:1520-4. https://doi.org/10.1016/S0026-0495(98)90080-4
  4. Hardwick JP, Osei-Hyiaman D, Wiland H, Abdelmegeed MA, Song BJ. PPAR/RXR regulation of fatty acid metabolism and fatty acid omega-hydroxylase (CYP4) isozymes: implications for prevention of lipotoxicity in fatty liver disease. PPAR Res 2009; 2009:952734.
  5. Carmena R. Type 2 diabetes, dyslipidemia, and vascular risk: rationale and evidence for correcting the lipid imbalance. Am Heart J 2005;150:859-70. https://doi.org/10.1016/j.ahj.2005.04.027
  6. Sugden MC, Holness MJ. Potential role of peroxisome proliferatoractivated receptor-alpha in the modulation of glucose-stimulated insulin secretion. Diabetes 2004;53 Suppl 1:S71-81. https://doi.org/10.2337/diabetes.53.2007.S71
  7. Robinson E, Grieve DJ. Significance of peroxisome proliferatoractivated receptors in the cardiovascular system in health and disease. Pharmacol Ther 2009;122:246-63. https://doi.org/10.1016/j.pharmthera.2009.03.003
  8. Manning PJ, Sutherland WH, Walker RJ, Williams SM, De Jong SA, Ryalls AR, Berry EA. Effect of high-dose vitamin E on insulin resistance and associated parameters in overweight subjects. Diabetes Care 2004;27:2166-71. https://doi.org/10.2337/diacare.27.9.2166
  9. Raso GM, Esposito E, Iacono A, Pacilio M, Cuzzocrea S, Canani RB, Calignano A, Meli R. Comparative therapeutic effects of metformin and vitamin E in a model of non-alcoholic steatohepatitis in the young rat. Eur J Pharmacol 2009;604:125-31. https://doi.org/10.1016/j.ejphar.2008.12.013
  10. Gonzalez R, Collado JA, Nell S, Briceno J, Tamayo MJ, Fraga E, Bernardos A, Lopez-Cillero P, Pascussi JM, Rufian S, Vilarem MJ, De la Mata M, Brigelius-Flohe R, Maurel P, Muntane J. Cytoprotective properties of alpha-tocopherol are related to gene regulation in cultured D-galactosamine-treated human hepatocytes. Free Radic Biol Med 2007;43:1439-52. https://doi.org/10.1016/j.freeradbiomed.2007.07.023
  11. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957;226:497-509.
  12. Winzell MS, Ahren B. The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes. Diabetes 2004;53 Suppl 3:S215-9.
  13. Facchini FS, Humphreys MH, DoNascimento CA, Abbasi F, Reaven GM. Relation between insulin resistance and plasma concentrations of lipid hydroperoxides, carotenoids, and tocopherols. Am J Clin Nutr 2000;72:776-9. https://doi.org/10.1093/ajcn/72.3.776
  14. Muis MJ, Stolk RP, Princen HM, Van Dam PS, Dikkeschei LD, Grobbee DE, Bilo HJ. alpha-Tocopherol levels in plasma in new-onset, insulin-dependent diabetes mellitus. Eur J Intern Med 2004;15:371-4. https://doi.org/10.1016/j.ejim.2004.04.018
  15. Paolisso G, D'Amore A, Giugliano D, Ceriello A, Varricchio M, D'Onofrio F. Pharmacologic doses of vitamin E improve insulin action in healthy subjects and non-insulin-dependent diabetic patients. Am J Clin Nutr 1993;57:650-6. https://doi.org/10.1093/ajcn/57.5.650
  16. Costacou T, Ma B, King IB, Mayer-Davis EJ. Plasma and dietary vitamin E in relation to insulin secretion and sensitivity. Diabetes Obes Metab 2008;10:223-8. https://doi.org/10.1111/j.1463-1326.2006.00683.x
  17. Codoner-Franch P, Navarro-Ruiz A, Fernandez-Ferri M, Arilla- Codoner A, Ballester-Asensio E, Valls-Belles V. A matter of fat: insulin resistance and oxidative stress. Pediatr Diabetes 2012;13: 392-9. https://doi.org/10.1111/j.1399-5448.2011.00847.x
  18. Rudich A, Tirosh A, Potashnik R, Khamaisi M, Bashan N. Lipoic acid protects against oxidative stress induced impairment in insulin stimulation of protein kinase B and glucose transport in 3T3-L1 adipocytes. Diabetologia 1999;42:949-57. https://doi.org/10.1007/s001250051253
  19. Maddux BA, See W, Lawrence JC Jr, Goldfine AL, Goldfine ID, Evans JL. Protection against oxidative stress-induced insulin resistance in rat L6 muscle cells by mircomolar concentrations of α-lipoic acid. Diabetes 2001;50:404-10. https://doi.org/10.2337/diabetes.50.2.404
  20. Vinayagamoorthi R, Bobby Z, Sridhar MG. Antioxidants preserve redox balance and inhibit c-Jun-N-terminal kinase pathway while improving insulin signaling in fat-fed rats: evidence for the role of oxidative stress on IRS-1 serine phosphorylation and insulin resistance. J Endocrinol 2008;197:287-96. https://doi.org/10.1677/JOE-08-0061
  21. Altavilla D, Deodato B, Campo GM, Arlotta M, Miano M, Squadrito G, Saitta A, Cucinotta D, Ceccarelli S, Ferlito M, Tringali M, Minutoli L, Caputi AP, Squadrito F. IRFI 042, a novel dual vitamin E-like antioxidant, inhibits activation of nuclear factor-kappaB and reduces the inflammatory response in myocardial ischemia-reperfusion injury. Cardiovasc Res 2000;47:515-28. https://doi.org/10.1016/S0008-6363(00)00124-3
  22. Terra X, Montagut G, Bustos M, Llopiz N, Ardevol A, Blade C, Fernandez-Larrea J, Pujadas G, Salvado J, Arola L, Blay M. Grape-seed procyanidins prevent low-grade inflammation by modulating cytokine expression in rats fed a high-fat diet. J Nutr Biochem 2009;20:210-8. https://doi.org/10.1016/j.jnutbio.2008.02.005
  23. Azzi A, Gysin R, Kempná P, Munteanu A, Villacorta L, Visarius T, Zingg JM. Regulation of gene expression by alpha-tocopherol. Biol Chem 2004;385:585-91.
  24. Braissant O, Foufelle F, Scotto C, Dauça M, Wahli W. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology 1996;137:354-66. https://doi.org/10.1210/endo.137.1.8536636
  25. Yu S, Matsusue K, Kashireddy P, Cao WQ, Yeldandi V, Yeldandi AV, Rao MS, Gonzalez FJ, Reddy JK. Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor gamma1 (PPARgamma1) overexpression. J Biol Chem 2003;278:498-505. https://doi.org/10.1074/jbc.M210062200
  26. Yakaryilmaz F, Guliter S, Savas B, Erdem O, Ersoy R, Erden E, Akyol G, Bozkaya H, Ozenirler S. Effects of vitamin E treatment on peroxisome proliferator-activated receptor-alpha expression and insulin resistance in patients with non-alcoholic steatohepatitis: results of a pilot study. Intern Med J 2007;37:229-35. https://doi.org/10.1111/j.1445-5994.2006.01295.x
  27. Serisier S, Leray V, Poudroux W, Magot T, Ouguerram K, Nguyen P. Effects of green tea on insulin sensitivity, lipid profile and expression of PPARalpha and PPARgamma and their target genes in obese dogs. Br J Nutr 2008;99:1208-16.
  28. Tsuboyama-Kasaoka N, Takahashi M, Kim H, Ezaki O. Upregulation of liver uncoupling protein-2 mRNA by either fish oil feeding or fibrate administration in mice. Biochem Biophys Res Commun 1999;257:879-85. https://doi.org/10.1006/bbrc.1999.0555
  29. Srivastava RA. Fenofibrate ameliorates diabetic and dyslipidemic profiles in KKAy mice partly via down-regulation of 11beta-HSD1, PEPCK and DGAT2. Comparison of PPARalpha, PPAR gamma, and liver × receptor agonists. Eur J Pharmacol 2009;607: 258-63. https://doi.org/10.1016/j.ejphar.2009.02.024
  30. Matsusue K, Haluzik M, Lambert G, Yim SH, Gavrilova O, Ward JM, Brewer B Jr, Reitman ML, Gonzalez FJ. Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes. J Clin Invest 2003;111: 737-47. https://doi.org/10.1172/JCI200317223

피인용 문헌

  1. Garlic extract attenuates brain mitochondrial dysfunction and cognitive deficit in obese-insulin resistant rats vol.39, pp.12, 2014, https://doi.org/10.1139/apnm-2014-0255
  2. Replacement of Dietary Saturated Fat by PUFA-Rich Pumpkin Seed Oil Attenuates Non-Alcoholic Fatty Liver Disease and Atherosclerosis Development, with Additional Health Effects of Virgin over Refined Oil vol.10, pp.9, 2015, https://doi.org/10.1371/journal.pone.0139196
  3. Optimized Rapeseed Oils Rich in Endogenous Micronutrients Protect High Fat Diet Fed Rats from Hepatic Lipid Accumulation and Oxidative Stress vol.7, pp.10, 2015, https://doi.org/10.3390/nu7105407
  4. Polyphenol-rich virgin olive oil reduces insulin resistance and liver inflammation and improves mitochondrial dysfunction in high-fat diet fed rats vol.61, pp.3, 2017, https://doi.org/10.1002/mnfr.201600418
  5. Responses of plasma glucose metabolism to exogenous insulin infusion in sheep-fed forage herb plantain and exposed to heat vol.11, pp.08, 2017, https://doi.org/10.1017/S1751731116002846
  6. Extraction Technology Can Impose Influences on Peanut Oil Functional Quality: A Study to Investigate the Lipid Metabolism by Sprague-Dawley Rat Model vol.84, pp.4, 2013, https://doi.org/10.1111/1750-3841.14457
  7. Anti-nociceptive effect of Arbutus andrachne L. methanolic leaf extract mediated by CB1, TRPV1 and PPARs in mouse pain models vol.28, pp.6, 2013, https://doi.org/10.1007/s10787-020-00746-y
  8. Long-term Proton Pump Inhibitor Administration Caused Physiological and Microbiota Changes in Rats vol.10, pp.None, 2013, https://doi.org/10.1038/s41598-020-57612-8